DOWNLOADS for AAADV 2019

downloads
Icon

Yescarta Kite Pharma

1 file(s)   2.58 MB
Icon

AAADV-20190508-Szarama

1 file(s)   567.65 KB
Icon

Eligibility Criteria Intro 2019

1 file(s)   991.63 KB
Icon

All Files for 2019 AAADV Workshop V3.0

1 file(s)   85mb
Icon

AAADV Satellite, Kluetz 2019

1 file(s)   1.14 MB
772019 AAADV 1Astellas 4Case Studies of Approved Agents 6Case Studies of Approved Agents II 4Companion Vs. Complementary Diagnostics​ 3Defining and Monitoring for SAEs 4Developing Drugs that Reduce the Burden of Cancer 2Endpoints Beyond ORR 6External Controls in Clinical Trials 22Friday May 10th 4Histology Agnostic Drug Development 20IN-DEPTH DISCUSSION GROUP II​ 15IN-DEPTH DISCUSSION GROUP III​ 19In-Depth Discussion Groups 1 4Initiating Master Protocols 7Liquid Biopsy - State of the Science and Future Directions 6MRD as Drug Development 4NGS - Clinical Utility and Regulatory Considerations 10Nonclinical Strategies to Support Emerging Complex Biologic Oncology Therapeutics 3Novel Therapeutic Interventions 6Patient Reported Outcomes 1PLENARY SESSION 3Plenary Session: Real World Evidence 2.0 1Revisiting Eligibility Criteria 1Roadmaps, Recommendations and Partnerships for Radiation Drug Development 3Satellites 3Symposium 2019 Defining the 26Thursday May 9th 32Wednesday May 8th 1Xospata® (gilteritinib) 1Yescarta (axicabtagene ciloleucel), Kite Pharma
Icon

Full Agenda Book

1 file(s)   1.97 MB
Icon

All Files for 2019 AAADV Workshop V3.0

1 file(s)   85mb
Icon

LOXO AAADV Slides final

1 file(s)   2.49 MB
Icon

XOSPATA

1 file(s)   1.86 MB
Icon

Nicholas Llosa

1 file(s)   2.70 MB
Icon

AAADV_Kisqali slides_ 05032019

1 file(s)   867.43 KB
Icon

Joshua

1 file(s)   1.09 MB
Icon

Kenneth Mandl AAADV

1 file(s)   3.31 MB
Icon

David Hong

1 file(s)   1.43 MB
Icon

RoomF_S Ghosh_AAADV 2019

1 file(s)   818.25 KB